Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. （開啟新視窗）

de Gast-Bakker DH, de Wilde RB, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, de Jonge E, Gesink-van der Veer BJ.

來源‎: Intensive Care Med 2013;39(11):2011-9.

檢索‎: PubMed 23995984

DOI碼‎: 10.1007/s00134-013-3085-7

https://www.ncbi.nlm.nih.gov/pubmed/23995984 （開啟新視窗）

Pediatric red blood cell transfusions increase resource use. （開啟新視窗）

Goodman AM, Pollack MM, Patel KM, Luban NL.

來源‎: J Pediatr 2003;142(2):123-7.

檢索‎: PubMed 12584531

DOI碼‎: 10.1067/mpd.2003.14

https://www.ncbi.nlm.nih.gov/pubmed/12584531 （開啟新視窗）

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. （開啟新視窗）

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

來源‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

檢索‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 （開啟新視窗）

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. （開啟新視窗）

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

來源‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

檢索‎: PubMed 22264414

DOI碼‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 （開啟新視窗）

Economic evaluation of cell salvage in pediatric surgery. （開啟新視窗）

Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM.

來源‎: Paediatr Anaesth 2013;23(11):1027-34.

檢索‎: PubMed 23952976

DOI碼‎: 10.1111/pan.12233

https://www.ncbi.nlm.nih.gov/pubmed/23952976 （開啟新視窗）